[Changes in interferon and thymus factor levels as well as in lymphocyte populations in patients with mammary carcinoma (author's transl)].
Changes in interferon and thymus factor as well as in cAMP levels and lymphocyte populations were recorded from patients with mammary carcinoma. They were equally recordable from those in whom no clinical tumour had been detectable at the time of postsurgical examinations as well as from patients with metastases distant from the primary tumour. The possibility for centralised disorder of immunological tumour cell defence in carcinoma patients is discussed.
D002293:Adenocarcinoma, Scirrhous / Q000276:immunology; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000276:immunology*; D003528:Carcinoma, Adenoid Cystic / Q000276:immunology; D000242:Cyclic AMP / Q000097:blood; D005260:Female; D006801:Humans; D007372:Interferons / Q000097:blood*; D007958:Leukocyte Count; D008875:Middle Aged; D013601:T-Lymphocytes / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D013951:Thymus Hormones / Q000097:blood*
D013951:Thymus Hormones; D007372:Interferons; D000242:Cyclic AMP
Veränderungen des Interferon- und Thymusfaktorspiegels sowie der Lymphozytenpopulationen bei Mammakarzinompatienten.